Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Lower risk of ICH with dabigatran as compared to warfarin in atrial fibrillation

    April 26, 2018

    Is dabigatran superior to warfarin with regards to the risk of intracranial hemorrhage and myocardial infarction in patients with atrial fibrillation?

  • 1
    News

    Impaired kidney function no problem for dabigatran reversal

    April 23, 2018

    ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.

  • 1
    News

    24-hour ambulatory BP measurements strongly predict mortality

    April 18, 2018

    Masked hypertension identified by 24-hour monitoring carried the greatest risk of death.

  • 1
    News

    High 5-year mortality in patients admitted with heart failure regardless of ejection fraction

    April 18, 2018

    Are there differences in 5-year outcomes in patients hospitalized with heart failure with preserved ejection fraction (ejection fraction [EF], greater than or equal to 50%), heart failure with borderline ejection fraction (EF, 41%-49%), or heart failure with reduced ejection fraction (EF, less than or equal to 40%)?

  • 1
    News

    Short Takes

    April 16, 2018

    Iron supplement dosing; immediate PCI

  • 1
    News

    Common infections are potent risk factor for MI, stroke

    April 13, 2018

    ORLANDO – Huge U.K. registry identifies a novel cardiovascular risk factor: hospitalization for UTI or respiratory infection.

  • 1
    News

    From #MeToo to troponins: Updates in hospital medicine

    April 13, 2018

    How do you summarize a year’s worth of hospitalist-relevant research in an hour?

  • 1
    News

    The ‘holy grail’ of thrombosis prevention

    April 13, 2018

    SAN DIEGO – One expert says it’s the ability to determine the risk of recurrence with or without continuation of anticoagulant treatment.

  • 1
    News

    Risk of ED visit/hospitalization increases when brand-name angiotensin receptor blockers (ARB) are switched to generic versions

    April 12, 2018

    Does switching from a brand name ARB to its generic lead to more ED visits and hospitalizations?

  • 1
    News

    Simvastatin, atorvastatin cut mortality risk for sepsis patients

    April 9, 2018

    In addition to supporting cardiac function and inhibiting inflammatory cytokines, these statins appear to exert a direct antimicrobial effect.

Previous1 … 60 61 62 63 64 … 80Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences